RevolKa Ltd., a venture-backed biotech company providing a game-changing protein engineering technology platform (Norio Hamamatsu, President and CEO) signed a master service agreement with Daiichi Sankyo Co., Ltd. (Hiroyuki Okuzawa, President and COO). RevolKa will create and deliver highly functional proteins, in collaboration with Daiichi Sankyo Co., Ltd. by...
Owkin, the first end-to-end TechBio unicorn that uses cutting-edge causal AI to unlock precision drug discovery, development and diagnostics, has unveiled an innovative drug pipeline in oncology and immunology following an exclusive global licensing agreement with Idorsia to develop and commercialize OKN4395, a clinic-ready best-in-class dual inhibitor of prostanoid...
Dr. Singh brings a track record of leadership and innovation from the FDA's Oncology Center of Excellence, with deep expertise in precision medicine and clinical development
Precision for Medicine, a global leader in biomarker-driven clinical research and development, announced that Harpreet Singh, MD, has joined the company as Chief Medical Officer....
Click Therapeutics, Inc., a leader in Digital Therapeutics™ as prescription medical treatments, announced plans to accelerate its development initiatives in obesity and cardiometabolic disease through the acquisition of the assets of Better Therapeutics, Inc. The assets acquired include AspyreRx (BT-001), the first FDA-authorized prescription digital therapeutic for type 2...
Red Hat, Inc., the world's leading provider of open source solutions, announced that Boston Children’s Hospital is piloting imaging analysis using Red Hat OpenShift for artificial intelligence (AI). The collaboration between Red Hat and Boston Children’s Hospital, one of the leading pediatric hospitals in the nation, is utilizing AI adoption in the...
TetraScience and Databricks announced a strategic partnership dedicated to helping life sciences organizations harness Scientific AI to bring more effective and safer therapies to market faster and less expensively.
The life sciences industry is racing to unlock data intelligence and harness the value of AI. Companies want to use their massive data...
HeartBeam, Inc., a medical technology company focused on transforming cardiac care through the power of personalized insights, announced new study data demonstrating that HeartBeam AI combined with vectorcardiography (VCG) outperformed an expert panel of heart rhythm cardiologists in detecting atrial flutter. HeartBeam AI is the company’s deep learning (a...
Huma.AI has joined the Microsoft Pegasus Program to enhance its generative AI platform for the life sciences industry. This collaboration with Microsoft will leverage Azure AI to accelerate the development of life-saving medicines and products. Huma.AI's platform significantly reduces the time required for evidence generation from weeks or months...
Trinity Biotech plc a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, announced a strategic collaboration with medical artificial intelligence (“AI”) company PulseAI to enhance the Company’s recently acquired continuous glucose monitor (CGM) biosensor technology.
Under this collaboration, Trinity Biotech will provide a...
Unlearn®, a leader in artificial intelligence research in medicine, announced the appointment of Steve Herne as its first Chief Commercial Officer. Herne will spearhead commercial strategies to propel the company’s growth following their successful Series C funding.
"Things continue to move fast at Unlearn, and Steve’s proven track record in...
